Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
University of Chicago
University of Chicago
National Cancer Institute (NCI)
Thomas Jefferson University
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Hackensack Meridian Health
Janssen Research & Development, LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hackensack Meridian Health
Hackensack Meridian Health
Hackensack Meridian Health
GlaxoSmithKline
Dana-Farber Cancer Institute
Hackensack Meridian Health
Celgene
National Cancer Institute (NCI)
Thomas Jefferson University
National Cancer Institute (NCI)
Janssen Research & Development, LLC
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Wake Forest University Health Sciences
Medical College of Wisconsin
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Pfizer
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
European Myeloma Network B.V.
Pfizer
Sanofi
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)